Literature DB >> 24255580

Human endogenous retroviral syncytin exerts inhibitory effect on invasive phenotype of B16F10 melanoma cells.

Hongbo Mo1, Dongyun Ouyang, Lihui Xu, Qi Gao, Xianhui He.   

Abstract

OBJECTIVE: Fusogenic endogenous retroviral syncytin plays an important role in the formation of syncytiotrophoblasts in human placenta. Apart from its expression in placenta, brain and testis, syncytin has also been found in many cancers. Although syncytin has been proposed to serve as a positive prognostic marker in some cancers, the underlying mechanism is unclear. The aim of this study is to evaluate the effects of syncytin expression on the invasive phenotype of melanoma cells.
METHODS: The eukaryotic expression plasmid for syncytin-EGFP was constructed and transfected into B16F10 melanoma cells. The effect of syncytin on the invasion potential of tumor cells was evaluated in B16F10 subline cells that stably expressed syncytin-EGFP fusion protein or EGFP alone.
RESULTS: The B16F10 sublines that stably expressed syncytin-EGFP or EGFP alone were established respectively and confirmed by immunofluorescent and immunoblotting assay. Syncytin expression in B16F10 cells was associated with decreased cell proliferation, migration and invasion. Multinucleated giant cells that contained as many as five nuclei were induced in syncytin-expressing cells. In addition, syncytin expression did not alter the sensitivity of B16F10 cells to trichosanthin, a toxin that damages syncytiotrophoblasts more efficiently than other tissues.
CONCLUSIONS: These results suggest that syncytin expression in some cancers may confine their invasion potential and thus serve as a positive prognostic factor.

Entities:  

Keywords:  Syncytin; cell fusion; invasiveness; melanoma; multinucleated cells

Year:  2013        PMID: 24255580      PMCID: PMC3828447          DOI: 10.3978/j.issn.1000-9604.2013.10.06

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  28 in total

1.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties.

Authors:  Pang-Chui Shaw; Ka-Ming Lee; Kam-Bo Wong
Journal:  Toxicon       Date:  2005-05       Impact factor: 3.033

3.  Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells.

Authors:  Yanting Zhang; Dongyun Ouyang; Lihui Xu; Yuhua Ji; Qingbing Zha; Jiye Cai; Xianhui He
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-06-02       Impact factor: 3.848

4.  Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.

Authors:  Oliver Frank; Michelle Giehl; Chun Zheng; Rüdiger Hehlmann; Christine Leib-Mösch; Wolfgang Seifarth
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Role of HERV-W syncytin-1 in placentation and maintenance of human pregnancy.

Authors:  Samina Noorali; Ioana C Rotar; Cindi Lewis; Joseph P Pestaner; Donald Gene Pace; Antonio Sison; Omar Bagasra
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-07

Review 6.  Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion.

Authors:  Berthold Huppertz; Clemens Bartz; Maria Kokozidou
Journal:  Micron       Date:  2006-02-07       Impact factor: 2.251

7.  Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis.

Authors:  Joseph M Antony; Yu Zhu; Maryam Izad; Kenneth G Warren; Mohammed Vodjgani; Francois Mallet; Christopher Power
Journal:  AIDS Res Hum Retroviruses       Date:  2007-10       Impact factor: 2.205

8.  Syncytin immunoreactivity in colorectal cancer: potential prognostic impact.

Authors:  Julie Mou Larsen; Ib Jarle Christensen; Hans Jørgen Nielsen; Ulla Hansen; Bolette Bjerregaard; Jan Fredrik Talts; Lars-Inge Larsson
Journal:  Cancer Lett       Date:  2009-03-26       Impact factor: 8.679

9.  Quantitative expression of the HERV-W env gene in human tissues.

Authors:  H-S Kim; K Ahn; D-S Kim
Journal:  Arch Virol       Date:  2008-07-05       Impact factor: 2.574

10.  Identification of the hASCT2-binding domain of the Env ERVWE1/syncytin-1 fusogenic glycoprotein.

Authors:  Valérie Cheynet; Guy Oriol; François Mallet
Journal:  Retrovirology       Date:  2006-07-04       Impact factor: 4.602

View more
  5 in total

1.  Interactions with Muscle Cells Boost Fusion, Stemness, and Drug Resistance of Prostate Cancer Cells.

Authors:  Berna Uygur; Evgenia Leikina; Kamran Melikov; Rafael Villasmil; Santosh K Verma; Calvin P H Vary; Leonid V Chernomordik
Journal:  Mol Cancer Res       Date:  2018-12-26       Impact factor: 5.852

2.  Research on tumorigenicity of cinnamaldehyde in melanoma cell lines and its mechanism.

Authors:  Ling Zhou; Yuangang Lu; Guihong Yang; Jinjin Wu
Journal:  Tumour Biol       Date:  2014-03-19

Review 3.  HERV Envelope Proteins: Physiological Role and Pathogenic Potential in Cancer and Autoimmunity.

Authors:  Nicole Grandi; Enzo Tramontano
Journal:  Front Microbiol       Date:  2018-03-14       Impact factor: 5.640

4.  Upregulation of syncytin-1 promotes invasion and metastasis by activating epithelial-mesenchymal transition-related pathway in endometrial carcinoma.

Authors:  Changmin Liu; Jiqin Xu; Feifei Wen; Fangfang Yang; Xiaoming Li; Dianzhong Geng; Lei Li; Jiming Chen; Jing Zheng
Journal:  Onco Targets Ther       Date:  2018-12-17       Impact factor: 4.147

5.  Osteoclast Fusion: Time-Lapse Reveals Involvement of CD47 and Syncytin-1 at Different Stages of Nuclearity.

Authors:  Anaïs Marie Julie Møller; Jean-Marie Delaissé; Kent Søe
Journal:  J Cell Physiol       Date:  2016-10-19       Impact factor: 6.384

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.